缓解期的儿童:瓦尔酸的天花板效应
Mariem Kammoun1, Rim Charfi1, Abir Boussetta2
1University of Tunis El Manar, Faculty of Medicine of Tunis, 1007, National Center of Pharmacovigilance Chalbi Belkahia, Department of Clinical Pharmacology, LR16SP02, 1006, Tunis, Tunisia.
La Tunisie medicale
|March 15, 2026
概括
治疗药物监测性儿童的酸发现,缓解的上限剂量为44.44 mg/kg/天. 较低剂量在缓解的儿童中是有效的,这表明治疗潜力优化.
科学领域:
- 儿科神经学 儿科神经学
- 临床药理学 临床药理学
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 对酸 (VPA) 的治疗药物监测 (TDM) 对于优化儿童治疗至关重要.
- 试管婴儿治疗旨在改善控制和早期发现耐药病例.
- 确定最佳的VPA剂量对于有效的儿科管理至关重要.
研究的目的:
- 在儿童中确定酸 (VPA) 的上限剂量.
- 为了确定与儿科缓解相关的VPA的低血清水平.
- 优化VPA治疗策略,以改善控制.
主要方法:
- 对2-18岁的儿童进行了回顾性研究.
- 包括13年 (2009-2022) 期间至少两次测量VPA最低水平的患者.
- 分析VPA剂量,血清水平,缓解状态和不良事件.
主要成果:
- 分析了88名儿童; 67%的儿童实现了缓解.
- 与非缓解组 (26.81 mg/kg/day) 相比,缓解组的平均VPA剂量较低 (21.53 mg/kg/day).
- 44.44毫克/公斤/天的上限剂量被确定为限制治疗有效性以实现缓解.
结论:
- 患有缓解的儿童的平均基于体重的VPA剂量低于那些不符合缓解标准的儿童.
- 确定了VPA的最高剂量为44.44 mg/kg/day,这表明治疗疗效的限制可以实现缓解.
- 这些发现支持在儿科中需要个性化的VPA剂量策略.
更多相关视频
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
01:24Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
01:20Antiepileptic Drugs: Potassium Channel Activators
895
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
895
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.5K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K